MARKET INTEL |
PRIME CONTRACT

Definitive Contract - W911SR19C0031

OVERVIEW

Awardee
Original Description
THE SCOPE OF THIS CONTRACT IS TO DEVELOP A SYSTEM CAPABLE OF REAL TIME, HIGH RESOLUTION ACQUISITION OF 3D STRUCTURAL INFORMATION FOR, BACTERIAL PATHOGENS AND HUMAN TISSUE.
Place of Performance
Andover, MA 1810 USA
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Related Opportunity
None

SBIR DETAILS

Research Type
Small Business Innovation Research Program (SBIR) Phase II
Title
Dual-mode T-DHM/IR Spectral Sensor for Real-time Pathogen Imaging
Abstract
Physical Sciences Inc. will develop a Tomographic Digital Holographic Microscope with integrated Infrared spectromicroscopy (T-DHM/IR) to enable time resolved correlation of chemical and 3D structural properties of biological warfare agents (BWAs), microorganisms and infected human tissue. The T-DHM/IR uses a precision hexapod stage and a custom reflective microscope objective with NA = 0.83 to perform simultaneous holographic imaging and wide field IR spectroscopy. 3D tomographic reconstructions are generated by rapidly acquiring holographic projections over a range of angles actuated by the hexapod stage; in this mode, the sensor will achieve diffraction-limited native lateral/axial resolutions of 240 nm/290 nm, respectively in < 9 s. Super resolution techniques applied to the T-DHM images will achieve practical lateral/axial resolutions of 120 nm/145 nm. The microscope also integrates a nearfield scanning optical microscopy approach to achieve sub-micron resolution in the IR spectroscopic channel registered to the T-DHM images. Under the Phase II effort, an advanced, ruggedized prototype, including software, will be developed and tested. The T-DHM/IR's capabilities will be benchmarked though studies of BWA simulants and environmental contaminants. It will also be used to advance reagent-free field testing for plasmodium and spirochete infections that cause malaria and Lyme's disease, respectively.
Topic Code
CBD171-003
Solicitation Number
17.1
Contact
David Weatherby
(978) 738-8107
weatherby@psicorp.com

STATUS
(Complete)

Period of Performance

8/8/19

Start Date

10/7/21

Current End Date

10/7/21

Potential End Date
100% Complete

Obligations

$999.9K

Total Obligated

$999.9K

Current Award

$999.9K

Potential Award
100% Funded

AWARD RELATIONSHIPS

Definitive Contract

W911SR19C0031

Subcontracts

-

Definitive Contract

W911SR19C0031

Subs

-

ACTIVITY TIMELINE

SUBCONTRACT AWARDS

Opportunity Lifecycle

HISTORY

COMPETITION
Solicitation Procedures
Negotiated Proposal/Quote
Number of Offers Received
2
Other Than Full and Open Competition
None
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

OTHER CATEGORIZATIONS

Subcontracting Plan
Plan Not Required
National Interest Action
None
IT Commercial Item Category
Not Applicable
AGENCY DETAIL
Created By
brian.mazen.w911sr@us.army.mil
Last Modified By
brian.mazen.w911sr@us.army.mil
Approved By
brian.mazen.w911sr@us.army.mil
Awarding Office
W911SR W6QK ACC-APG
Funding Office
W91B94 USA CCDC CHEMICAL BIOLOGICAL CENTER

LEGISLATIVE MANDATES

Clinger-Cohen Act Compliant
No
Construction Wage Rate Requirements
Not Applicable
Labor Standards
Not Applicable
Materials, Supplies, Articles & Equipment
Not Applicable
Last Modified: 7/7/21


PIID: W911SR-19-C-0031